Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

513 Press Releases
DateTitleCompany
28 Aug 12 Inspra significantly reduces risk of recurrent heart failure hospitalization Pfizer
28 Aug 12 Pfizer Announces Conclusion of Consent Solicitation For $22.5 Million of Debt Pfizer Inc.,
Published by
Business Wire
24 Aug 12 Pfizer Announces Successful Consent Solicitation Results For Three Series Of Debt Pfizer Inc.,
Published by
Business Wire
21 Aug 12 U.S. Food And Drug Administration Extends Action Date For Tofacitinib New Drug Application By Three Months Pfizer Inc.,
Published by
Business Wire
16 Aug 12 Pfizer Commences Consent Solicitation for Amendments to Pharmacia Indentures Pfizer Inc.,
Published by
Business Wire
14 Aug 12 Pfizer And Astrazeneca Enter Into Agreement For Over-The-Counter Nexium Pfizer Inc.,
Published by
Business Wire
13 Aug 12 Zoetisâ„¢ Files IPO Registration Statement Pfizer Inc.,
Published by
Business Wire
10 Aug 12 Pfizer Reports Results From Phase 3 Study Of Torisel (temsirolimus) In Combination With Bevacizumab In Advanced Renal Cell Carcinoma (RCC) Pfizer Inc.,
Published by
Business Wire
07 Aug 12 Pfizer Announces Resolutions with DOJ and SEC Related to Certain International Operations Pfizer Inc.,
Published by
Business Wire
07 Aug 12 SIGNIFICANTLY MORE PATIENTS WHO USE CHAMPIX?® (varenicline) ARE STILL SMOKE FREE AFTER ONE YEAR COMPARED WITH THOSE WHO USE NRT PATCH AND COMBINATION NRT1 Pfizer
07 Aug 12 Pfizer Announces Co-Primary Clinical Endpoints Not Met In Second Phase 3 Bapineuzumab Study In Mild-To-Moderate Alzheimer’s Disease Patients Who Do Not Carry The Apoe4 Genotype Pfizer Inc.,
Published by
Business Wire
07 Aug 12 Summertime Shines a Light on the Need for Vitamin D Pfizer,
Published by
Business Wire
03 Aug 12 Study Shows Toviaz Is Effective In Reducing Urge Urinary Incontinence In Patients With Overactive Bladder After Suboptimal Response To Detrol LA Pfizer Inc.,
Published by
Business Wire
31 Jul 12 Pfizer Announces Positive Top-Line Results From The ORAL Start Phase 3 Study Of Tofacitinib In Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
31 Jul 12 Pfizer supports the use of Prevenar 13® as an important option to prevent Pfizer
31 Jul 12 Pfizer Reports Second-Quarter 2012 Results Pfizer Inc.,
Published by
Business Wire
24 Jul 12 Pfizer Announces Topline Results Of First Of Four Studies In Bapineuzumab Phase 3 Program Pfizer Inc.,
Published by
Business Wire
23 Jul 12 Pfizer Reports Top-Line Results of EU Post-Authorization Safety and Efficacy Study of Lyrica’s Discontinuation Effects In Patients with Generalized Anxiety Disorder Pfizer Inc.,
Published by
Business Wire
23 Jul 12 Pfizer Reports Top-Line Results of Study of Lyrica’s Effect on Male Reproduction Conducted as a Post-Approval Commitment Required by the U.S. Food and Drug Administration Pfizer Inc.,
Published by
Business Wire
20 Jul 12 Pfizer’s Crizotinib Receives Positive Opinion For Conditional Marketing Authorization From The Committee For Medicinal Products For Human Use For The Treatment Of Adults With Previously Treated ALK-Positive Advanced Non-Small Cell Lung Cancer In The EU Pfizer,
Published by
Business Wire
20 Jul 12 Pfizer and Northwestern University Win LYRICA® Patent Case in Delaware District Court Pfizer Inc.,
Published by
Business Wire
19 Jul 12 European Medicines Agency Accepts Regulatory Submission For Bazedoxifene/Conjugated Estrogens For The Treatment Of Symptoms Associated With Menopause And Osteoporosis Pfizer Inc.,
Published by
Business Wire
09 Jul 12 Inspra (eplerenone) accepted for use within NHS Scotland Pfizer
29 Jun 12 Pfizer Declares A 22-Cent Third-Quarter 2012 Dividend Pfizer Inc.,
Published by
Business Wire
26 Jun 12 Pfizer Invites Public to View and Listen to Webcast of July 31 Conference Call with Analysts Pfizer Inc.,
Published by
Business Wire
25 Jun 12 Bristol-Myers Squibb and Pfizer Receive Complete Response Letter from U.S. Food and Drug Administration for ELIQUIS® (apixaban) Pfizer Inc.,
Published by
Business Wire
22 Jun 12 REAL-WORLD DATA REINFORCE CLINICAL EFFICACY OF XIAPEX® IN THE TREATMENT OF DUPUYTREN’S CONTRACTURE Pfizer
21 Jun 12 FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review Pfizer Inc.,
Published by
Business Wire
20 Jun 12 Pfizer Statement Regarding Prevnar 13® Receiving ACIP Recommendation for Prevention of Pneumococcal Disease in Adults With Immunocompromising Conditions Pfizer Inc,
Published by
Business Wire
19 Jun 12 Pfizer Announces Positive Results From Phase 3 Study PROFILE 1007 Evaluating XALKORI® (crizotinib) In Previously Treated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
Advertising